LFB BIOMEDICAMENTS
SIREN 491371167
No insolvency procedure
No collective procedure published in the BODACC window loaded by Solvenda. Monitoring continues daily.
Index compliant
- Score published : 98/100 (edition 2025)
- Previous edition (2024) : 98/100
- Headcount band : 1000 et plus
- Sector : Industrie manufacturière
- Department : Essonne
Source: Gender Equality Index published by the French Ministry of Labour, Open Licence 2.0. Absence from an edition may also mean the company left the obligation.
1 agreement(s) filed, 1 with a term date
| Agreement | Theme | Term |
|---|---|---|
| ACCORD A DUREE DETERMINEE RELATIF A LA POLITIQUE D’ACCOMPAGNEMENT SOCIAL DE LA MOBILITE INTERNE VERS LE SITE D’ARRAS | Système de rémunération (autres qu'évolution) | 123 days (2026-12-31) |
Source: ACCO database of company agreements, DILA and Légifrance, Open Licence 2.0.
Solvenda watches for you, every morning.
Monitor this SIREN and your whole portfolio automatically.
Get started Risk index →Frequently asked questions
Is LFB BIOMEDICAMENTS in insolvency proceedings?
No collective procedure is published in the BODACC for SIREN 491371167 in the window loaded by Solvenda. This is not a solvency guarantee; monitoring continues daily.
Does the absence of a BODACC procedure guarantee solvency?
No. It only proves no insolvency procedure is published to date. Continuous monitoring by SIREN remains necessary.
What is the gender equality index of LFB BIOMEDICAMENTS?
LFB BIOMEDICAMENTS published a score of 98 for the 2025 edition. Below 75, a company has three years to correct, failing which a penalty of up to 1% of payroll may apply.
Does LFB BIOMEDICAMENTS have collective agreements?
1 company agreement(s) filed by LFB BIOMEDICAMENTS appear in the public ACCO database, of which 1 reach their term within twelve months.